Professional Information
Accreditations and Certifications
Critical Call List (PDF)
Specimen Collection/Containers
Testing Turnaround
Laboratory Services
Lab Request Form
Client Services
Cytopathology Services
Laboratory Services
Phlebotomy Services
Lab Test Directory
| UWHC Lab Test Details | |
|---|---|
| Test Name | STR Engraftment Unseparated Lineages, Bone Marrow (Post-Tx) |
| Test Code(s) | HCSTREBM |
| CPT Code(s) | 81267 |
| Methodology | PCR |
| Clinical Information | Typically used to assess proportions of donor and recipient derived nucleated cells post stem cell transplant or in cases of suspected graft-vs-host disease. |
| Days Performed | Once a week. |
| In-Lab Turnaround Time | 10 days. |
| Stat In-Lab Turnaround Time | Not available stat. |
| Collection Requirements | |||
|---|---|---|---|
| Specimen | Bone marrow aspirate | ||
| Collection Container |
| ||
| Collection Instructions | Extracted nucleic acid specimens may occasionally be received in cases where no primary sample is available for testing. All nucleic acid specimens received for testing must have been extracted in a CLIA-certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or the CMS. | ||
| Collection Volume | 1 mL | ||
| Pediatric Collection Volume | 1 mL | ||
| Specimen Processing Requirements | |||||||
|---|---|---|---|---|---|---|---|
| Stability |
| ||||||
| Sample Analyzed | Bone Marrow Aspirate | ||||||
| Testing Volume | 1 mL | ||||||
| Pediatric Testing Volume | 0.6 mL | ||||||
| Specimen Processing | Do not freeze | ||||||
| Outreach Specimen Processing | Refrigerate specimen. Do not freeze or centrifuge. | ||||||
| Specimen Transport | Transport specimen to Laboratory. | ||||||
| Interpretation | |||||||
|---|---|---|---|---|---|---|---|
| |||||||
| Test Limitations | Test requires pre-transplant DNA samples on file in the laboratory for recipient and donor. | ||||||
| Additional Information | The performance characteristics of this test were validated by UWHC Clinical Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The UWHC Clinical Laboratories is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing. | ||||||
